Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer
2014
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
The treatment of early breast cancer in women over the age of 70
2011
Breast cancer
2019 Standout
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
Prevalence of pain in patients with breast cancer post-treatment: A systematic review
2018
Contemporary Breast Radiotherapy and Cardiac Toxicity
2015
The Evolving Role of Partial Breast Irradiation in Early-Stage Breast Cancer
2013
Breast cancer
2016 Standout
Evidence-Based Management of Anticoagulant Therapy
2012
Contribution of platelets to tumour metastasis
2011 Standout
Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement
2016
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons
2010
Glioblastoma and Other Malignant Gliomas
2013 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Thromboembolic disease in patients with high-grade glioma
2012
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
2012
Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial
2018
Second international consensus guidelines for breast cancer in young women (BCY2)
2016
Hepatocellular carcinoma
2021 Standout
Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy
2018
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial
2015
Accelerated partial irradiation for breast cancer: Systematic review and meta-analysis of 8653 women in eight randomized trials
2014
The landscape of long noncoding RNAs in the human transcriptome
2015 Standout
Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial
2011
Sucralfate
1991
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Antithrombotic Therapy for VTE Disease
2012 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials
2013
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
2001 Standout
Tumor Bed Boost Integration during Whole Breast Radiotherapy: A Review of the Current Evidence
2014
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial
2020
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2013
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Benefits, risks, and safety of external beam radiation therapy for breast cancer
2015
D‐dimer at venous thrombosis diagnosis is associated with risk of recurrence
2017
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Maftools: efficient and comprehensive analysis of somatic variants in cancer
2018 Standout
Effectiveness of different accelerated partial breast irradiation techniques for the treatment of breast cancer patients: Systematic review using indirect comparisons of randomized clinical trials
2019
Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer
2014
First international consensus guidelines for breast cancer in young women (BCY1)
2014
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015
Over-irradiation
2016
Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments
2018
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
2015
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function
2017
Management of glioblastoma: State of the art and future directions
2020 Standout
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
2015 Standout
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
2003 Standout
Progress and controversies: Radiation therapy for invasive breast cancer
2013
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Cancer, Clots and Consensus: New Understanding of an Old Problem
2009
Breast Cancer Treatment
2019 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer
2015
Cancer treatment and survivorship statistics, 2016
2016 Standout
Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
2016
Metabolic reprogramming and cancer progression
2020 StandoutScience
Cancer treatment and survivorship statistics, 2019
2019 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Adjuvant Photothermal Therapy Inhibits Local Recurrences after Breast-Conserving Surgery with Little Skin Damage
2017
Recent progress in the treatment and prevention of cancer‐related lymphedema
2014
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Accelerated partial breast irradiation: Current status with a focus on clinical practice
2018
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Works of Sameer Parpia being referenced
Interim Cosmetic and Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation Using Three-Dimensional Conformal External Beam Radiation Therapy
2013
Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism
2011
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
2010 Standout
Treatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer
2014
PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
2010
D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment
2016
Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy
2014
Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios
2011
Interim Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation (APBI) Using 3D Conformal External Beam Radiation Therapy (3D CRT)
2012
Sucralfate reduces the gastrointestinal absorption of norfloxacin
1989
2015
Randomized Trial of Decongestive Lymphatic Therapy for the Treatment of Lymphedema in Women With Breast Cancer
2013
Randomized phase II placebo-controlled trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone receptor-positive metastatic breast cancer (MBC): OCOG Zamboney study—NCT00811369.
2013